Corcept Therapeutics CORT
NASDAQ CORT
$115.23 +0.49 (+0.43%)
At close: Sep 30, 2026 · 4:00 PM EDT

Corcept Therapeutics (CORT) Cash from Operations (2010 - 2026)

Updated

Corcept Therapeutics (CORT) recorded Cash from Operations of $33.54 million in Q2 2026, down 24.3% from $44.3 million a year earlier.

Analysis

Corcept Therapeutics (CORT) Cash from Operations (2010 - 2026) Analysis & Trends

On a TTM basis, Corcept Therapeutics' Cash from Operations came in at $109.7 million as of Jun 30, 2026, down 39.9% year-over-year; for FY2025, it came in at $142 million, down 28.4% from FY2024.

  • Annual Cash from Operations has a five-year compound annual growth rate of -1.3% (FY2020 to FY2025).
  • Across earlier years, Cash from Operations came in at $198.3 million in FY2024 (+56.5%), $126.68 million in FY2023 (+5.3%), $120.32 million in FY2022 (-28.3%) and $167.89 million in FY2021 (+10.5%).
  • Quarterly Cash from Operations has ranged from -$16.77 million in Q1 2026 to $73.29 million in Q3 2024 over the past five years.
  • On a year-over-year basis, Cash from Operations rose in three of the last seven quarters, with growth averaging 123.8%.
  • Peak year-over-year performance for Cash from Operations in the last five years was growth of 986.2% in Q4 2024, against a decline of 83.4% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -$16.77 million (Q1 2026), $38.45 million (Q4 2025) and $54.48 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 8.62 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.44 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.58 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.57 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 835.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.13 Bn
10 Corcept Therapeutics 12.46 Bn 11.02 Bn 252.09 Mn 33.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.54 Mn
Mar 31, 2026 -16.77 Mn
Dec 31, 2025 38.45 Mn
Sep 30, 2025 54.48 Mn
Jun 30, 2025 44.30 Mn
Mar 31, 2025 4.77 Mn
Dec 31, 2024 60.06 Mn
Sep 30, 2024 73.29 Mn
Jun 30, 2024 41.19 Mn
Mar 31, 2024 23.76 Mn
Dec 31, 2023 5.53 Mn
Sep 30, 2023 52.91 Mn
Jun 30, 2023 42.29 Mn
Mar 31, 2023 25.96 Mn
Dec 31, 2022 33.39 Mn
Sep 30, 2022 33.65 Mn
Jun 30, 2022 18.04 Mn
Mar 31, 2022 35.25 Mn
Dec 31, 2021 49.43 Mn
Sep 30, 2021 48.70 Mn
API Access

Corcept Therapeutics Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=CORT&period=max&api_key=YOUR_API_KEY